299-86-5|Crufomate - Shanghai Canbi Pharma Ltd.

Current Location
Home Products
detail

Crufomate | CAS:299-86-5

Crufomate

Name：Crufomate
CAS：299-86-5
Synonyms：4-tert-Butyl-2-chlorophenyl N-methyl O-methylphosphoramidate; 4-tert-Butyl-2-chlorophenyl methyl N-methylphosphoramidate; 4-tert-Butyl-2-chlorophenyl methyl methylphosphoramidate; Amidofos; Amidophos; Crufomat; Crufomate; Dowco 132; Montrel; NSC 253463; Ruelene; Ruelene drench
Molecular Formula：C₁₂H₁₉ClNO₃P
Molecular Weight：291.71
EINESC：206-083-1

Description

Properties

Melting point	60 ºC
Density	1.176

Safety

Symbol(GHS)	Xn;N
Hazard Codes	R21/22;R50/53
SDS/MSDS	S36/37;S60;S61

SDS

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

A nitrogen-15 nuclear magnetic resonance study of the acid-base and tautomeric equilibriums of 4-substituted imidazoles and its relevance to the catalytic mechanism of .alpha.-lytic protease.Roberts, J. D. , et al. Journal of the American Chemical Society, 104, 3945-3949 (1982) A covalent nicotinamide adenine dinucleotide intermediate in the urocanase reaction.L H Matherly et al.Biochemistry, 21(11), 2789-2794 (1982-05-25) Urocanate reductase: identification of a novel anaerobic respiratory pathway in Shewanella oneidensis MR-1.Alexander V Bogachev et al.Molecular microbiology, 86(6), 1452-1463 (2012-10-20) Biochemical study of malnutrition. Part VI: Histidine and its metabolites.I Antener et al.International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, 53(2), 199-209 (1983-01-01) Histidine metabolism in the human adult: histidine blood tolerance, and the effect of continued free L-histidine ingestion on the concentration of imidazole compounds in blood and urine.W D Block et al.The Journal of nutrition, 91(2), 189-194 (1967-02-01) Imidazolepropionic acid as a urinary metabolite of L-histidine.N P SEN et al.Biochemical and biophysical research communications, 9, 257-261 (1962-10-17)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News